7.3(top 2%)
impact factor
20.8K(top 1%)
papers
1.2M(top 1%)
citations
437(top 0.1%)
h-index
7.5(top 5%)
extended IF
31.7K
all documents
1.2M
doc citations
687(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1New Guidelines to Evaluate the Response to Treatment in Solid TumorsJournal of the National Cancer Institute200014,895
2The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJournal of the National Cancer Institute199312,691
3New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJournal of the National Cancer Institute19908,514
4Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJournal of the National Cancer Institute19985,264
5Statistical Aspects of the Analysis of Data From Retrospective Studies of DiseaseJournal of the National Cancer Institute04,761
6What Is the Evidence That Tumors Are Angiogenesis Dependent?Journal of the National Cancer Institute19904,235
7The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States TodayJournal of the National Cancer Institute19813,425
8Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJournal of the National Cancer Institute19953,039
9Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJournal of the National Cancer Institute19892,971
10Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJournal of the National Cancer Institute19912,914
11Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite InstabilityJournal of the National Cancer Institute20042,796
12Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck CancersJournal of the National Cancer Institute20002,624
13Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular AspectsJournal of the National Cancer Institute20012,622
14Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJournal of the National Cancer Institute20082,442
15Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-AnalysisJournal of the National Cancer Institute20142,309
16Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung CancersJournal of the National Cancer Institute20052,217
17Projections of the Cost of Cancer Care in the United States: 2010-2020Journal of the National Cancer Institute20112,193
18A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2Journal of the National Cancer Institute19732,094
19In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2Journal of the National Cancer Institute19732,025
20Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJournal of the National Cancer Institute20091,870
21Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve PrognosisJournal of the National Cancer Institute20061,853
22Drug Resistance and the Solid Tumor MicroenvironmentJournal of the National Cancer Institute20071,838
23Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic OligodendrogliomasJournal of the National Cancer Institute19981,766
24Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJournal of the National Cancer Institute19921,698
25Tobacco Smoke Carcinogens and Lung CancerJournal of the National Cancer Institute19991,689
26Intrinsic Resistance of Tumorigenic Breast Cancer Cells to ChemotherapyJournal of the National Cancer Institute20081,655
27Nutrition Intervention Trials in Linxian, China: Supplementation With Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-Specific Mortality in the General PopulationJournal of the National Cancer Institute19931,626
28A Family of Drug Transporters: the Multidrug Resistance-Associated ProteinsJournal of the National Cancer Institute20001,589
29Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology StudiesJournal of the National Cancer Institute20041,583
30A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate CarcinomaJournal of the National Cancer Institute20021,565
31Design and Endpoints of Clinical Trials in Hepatocellular CarcinomaJournal of the National Cancer Institute20081,554
32Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working GroupJournal of the National Cancer Institute20111,553
33Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective StudiesJournal of the National Cancer Institute20021,532
34Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerJournal of the National Cancer Institute20051,524
35Cancer Risks in BRCA2 Mutation CarriersJournal of the National Cancer Institute19991,466
36Phases of Biomarker Development for Early Detection of CancerJournal of the National Cancer Institute20011,464
37Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJournal of the National Cancer Institute20061,456
38Changing views of the role of matrix metalloproteinases in metastasisJournal of the National Cancer Institute19971,444
39Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition StagingJournal of the National Cancer Institute20041,434
40One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23Journal of the National Cancer Institute19771,427
41Overdiagnosis in CancerJournal of the National Cancer Institute20101,424
42Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck CancersJournal of the National Cancer Institute20081,358
43Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJournal of the National Cancer Institute19891,349
44Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical TrialJournal of the National Cancer Institute20081,343
45Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)Journal of the National Cancer Institute20051,335
46Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesJournal of the National Cancer Institute20021,312
47Tomatoes, Tomato-Based Products, Lycopene, and Cancer: Review of the Epidemiologic LiteratureJournal of the National Cancer Institute19991,273
48Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III TrialJournal of the National Cancer Institute19961,253
49Evidence for a Novel Gene Associated With Low Tumor Metastatic PotentialJournal of the National Cancer Institute19881,239
50Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *Journal of the National Cancer Institute19941,239